Celon Pharma SA (CLN) — Defensive Interval Ratio
Celon Pharma SA (CLN) has a Defensive Interval Ratio of 181 days as of March 2026. Defensive assets of zł53.38 Million (cash zł-, short-term investments zł747.00K, receivables zł52.63 Million) cover 181 days of daily cash needs of zł295.56K/day. See CLN current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Celon Pharma SA Defensive Interval Ratio (2012–2024)
This chart shows how Celon Pharma SA's Defensive Interval Ratio has evolved across 13 annual periods from 2012 to 2024. As of March 2026, the ratio stands at 181 days, meaning defensive assets of zł53.38 Million can fund 181 days of operations without new revenue. See Celon Pharma SA (CLN) net asset quality to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Celon Pharma SA (2012–2024)
The table below presents the year-by-year Defensive Interval Ratio for Celon Pharma SA from 2012 to 2024, covering 13 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see CLN stock market capitalisation.
| Year | DIR (days) | Defensive Assets (PLN) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 386 days | zł92.25 Million | zł238.69K/day | zł- | zł48.24 Million | ▼ -165 days |
| 2023 | 551 days | zł130.42 Million | zł236.54K/day | zł- | zł82.18 Million | ▲ +190 days |
| 2022 | 362 days | zł115.42 Million | zł319.01K/day | zł- | zł81.72 Million | ▼ -90 days |
| 2021 | 452 days | zł107.00 Million | zł236.61K/day | zł- | zł79.75 Million | ▲ +335 days |
| 2020 | 117 days | zł36.70 Million | zł312.73K/day | zł- | zł13.00K | ▼ -456 days |
| 2019 | 573 days | zł40.80 Million | zł71.19K/day | zł- | zł318.00 | ▼ -1171 days |
| 2018 | 1745 days | zł94.24 Million | zł54.02K/day | zł- | zł54.48 Million | ▲ +1076 days |
| 2017 | 668 days | zł34.74 Million | zł51.98K/day | zł- | zł-90.59K | ▼ -53 days |
| 2016 | 721 days | zł28.15 Million | zł39.02K/day | zł- | zł1.44 Million | ▲ +502 days |
| 2015 | 219 days | zł21.94 Million | zł100.14K/day | zł- | zł632.65K | ▼ -165 days |
| 2014 | 385 days | zł19.28 Million | zł50.14K/day | zł- | zł590.14K | ▲ +32 days |
| 2013 | 353 days | zł10.32 Million | zł29.27K/day | zł- | zł175.65K | ▲ +349 days |
| 2012 | 4 days | zł150.13K | zł38.97K/day | zł- | zł150.13K | — |